Target intelligence / Profile preview

LINGO1 antisense RNA 2 (LINGO1-AS2)

Target
LINGO1-AS2
Molecular classification
Other, long non-coding RNA, antisense RNA
01

Overview

LINGO1 antisense RNA 2 (LINGO1-AS2) is a long non-coding RNA transcribed from the LINGO1 locus in the antisense direction relative to the LINGO1 protein-coding gene. Like other antisense lncRNAs, LINGO1-AS2 does not code for a protein but is thought to play a regulatory role over LINGO1 gene expression, primarily through mechanisms possible in cis (acting near its own locus). Antisense lncRNAs can regulate their sense gene partners by affecting transcription, promoter/enhancer activity, chromatin structure, or by direct RNA-mediated action. In general, antisense RNAs may serve either oncogenic or tumor-suppressive functions and are increasingly being viewed as therapeutic targets or agents, although there is currently no direct evidence or clinical application for LINGO1-AS2 itself. More broadly, LINGO1 protein itself is implicated as a central regulator of neuronal survival, myelination, and axonal regeneration in the central nervous system, but LINGO1-AS2's exact biological and pathological roles remain to be clarified.

Other names
LINGO1-AS2
02

Mechanism of action

Antisense lncRNAs in general may regulate neighboring gene expression, sometimes by modulating chromatin state, interfering with transcription, or RNA-RNA interactions, but no specific mechanism of action for drugs targeting LINGO1-AS2 is known.

03

Biological functions

Regulation of gene expression, likely in cis with effects on the LINGO1 gene
04

Disease associations

Cancer (specific role for LINGO1-AS2 not firmly established, but some antisense lncRNAs are oncogenic or tumor suppressive)Neurodegenerative diseases (general roles for antisense RNAs deduced by their relation to host genes)
05

Safety considerations

Possible off-target effectsUnintended regulation (general lncRNA targeting issues)

Beyond the preview

Go deeper on LINGO1 antisense RNA 2 (LINGO1-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LINGO1 antisense RNA 2 (LINGO1-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call